Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

31 results

Discover our SPC booklet

Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs).

Nynke Brouwer new senior associate at Stibbe

We are pleased to announce that Nynke Brouwer will be joining Stibbe’s Amsterdam office as senior associate. Her appointment as from 13 June 2022 will further strengthen our TMT/IP practice.

Podcast: Product counseling en intellectueel eigendom

In de nieuwe podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten.

Het federale regeerakkoord door een publiekrechtelijke bril

De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.

Stibbe advises Avista Capital Partners

Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.

Contracts & Corona: force majeure and related topics

The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.

Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review

Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. 

 

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures

The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.

Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective”

Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Legal Considerations for Artificial Intelligence in the Life Sciences Sector

This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.

Digital Law Up(to)date: No processing of vaccination status in recruitment process

The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.

Le chômage temporaire est-il antidote au coronavirus?

L’ONEM a confirmé que les employeurs peuvent, dans certaines situations, mettre des travailleurs en chômage temporaire pour force majeure en raison du coronavirus.

Pagination

  • Current page 1
  • Page 2
  • Next page
Reset filters
Date
Content type
  • Article (15)
  • Event (1)
  • Inside Stibbe (1)
  • Matter (13)
  • Podcast (1)
Expertise
  • (-) Healthcare and Life Sciences (31)
  • Audit Firms and Accountancy (12)
  • Banking and Finance (111)
  • Capital Markets (69)
  • Compliance, Sanctions and Risk (29)
  • Corporate and M&A (195)
  • Corporate Investigations (8)
  • Criminal Law and Enforcement (41)
  • Employment, Benefits and Pensions (73)
  • Energy, Industry and Climate (103)
  • Environment and Planning (149)
  • ESG & Sustainability (72)
  • EU and Competition Law (324)
  • Financial Regulation (64)
  • Infrastructure and Mobility (60)
  • Insurance (14)
  • Intellectual Property (63)
  • Investment Funds (41)
  • Litigation and Arbitration (99)
  • Mass Litigation (12)
  • Privacy and Data Protection (122)
  • Private Equity (43)
  • Procurement Law (55)
  • Public Law (189)
  • Real Estate (135)
  • Restructuring and Insolvency (18)
  • Sports (7)
  • Tax (97)
  • Tech (93)
  • Technology, Media and Telecommunications (189)
  • Unfair Competition and Consumer Protection (174)
Jurisdiction
  • (-) BE Law (23)
  • (-) EU Law (14)
  • LU Law (7)
  • NL Law (44)
Language
  • Dutch (3)
  • English (26)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information